Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
14 The SURMOUNT-3 trial compares tirzepatide to placebo in patients without T2DM but who have obesity or are overweight with associated comorbidities
Dosing: Start 0.75 mg SC once weekly at any time of day, with or without meals
Research Diets, D12108 C, 1.25% cholesterol) or an ALC-supplemented diet (600 mg/kg, Changzhou Shuiyushuer Company, Changzhou, China) for 8 weeks (Control group, n = 4
a consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD)
US$ 24.02
US$ 20.96
US$ 29.17
US$ 28.38
US$ 29.55
